BD India Initiated Workshop aims to achieve consensus in Standardizing AML-MRD Assay by Flow Cytometry Testing

To achieve a consensus on a suitable panel and analysis strategy to report Acute Myeloid Leukemia - Measurable Residual Disease (AML-MRD) by flow cytometry, BD

Related Keywords

India ,Chennai ,Tamil Nadu ,Delhi ,New Delhi ,Gurgaon ,Haryana ,Arun Kumar Arunachalam ,Puneet Talwar ,Paresh Jain ,Sehgal Path Lab Mumbai ,World Of Health ,Department Of Haematology ,Centers Of Excellence ,Max Healthcare Institute Ltd ,Laboratory Services ,Bd Life Sciences ,Newsvoirnew Delhi ,Acute Myeloid Leukemia ,Residual Disease ,Associate Director ,Anil Handoo ,Senior Director ,Max Super Specialty Hospital ,Assistant Professor ,Apollo Chennai ,Action Cancer Hospital Delhi ,Atul Grover ,Managing Director ,South Asia ,Flow Cytometry ,